KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zimmer Biomet Holdings (ZBH) Cash & Equivalents (2016 - 2025)

Zimmer Biomet Holdings has reported Cash & Equivalents over the past 17 years, most recently at $591.9 million for Q4 2025.

  • Quarterly results put Cash & Equivalents at $591.9 million for Q4 2025, up 12.64% from a year ago — trailing twelve months through Dec 2025 was $591.9 million (up 12.64% YoY), and the annual figure for FY2025 was $591.9 million, up 12.64%.
  • Cash & Equivalents for Q4 2025 was $591.9 million at Zimmer Biomet Holdings, down from $1.3 billion in the prior quarter.
  • Over the last five years, Cash & Equivalents for ZBH hit a ceiling of $1.4 billion in Q1 2025 and a floor of $292.1 million in Q3 2023.
  • Median Cash & Equivalents over the past 5 years was $480.6 million (2022), compared with a mean of $595.0 million.
  • Biggest five-year swings in Cash & Equivalents: plummeted 70.24% in 2021 and later surged 252.29% in 2025.
  • Zimmer Biomet Holdings' Cash & Equivalents stood at $378.1 million in 2021, then decreased by 0.63% to $375.7 million in 2022, then grew by 10.67% to $415.8 million in 2023, then grew by 26.38% to $525.5 million in 2024, then grew by 12.64% to $591.9 million in 2025.
  • The last three reported values for Cash & Equivalents were $591.9 million (Q4 2025), $1.3 billion (Q3 2025), and $556.9 million (Q2 2025) per Business Quant data.